Cancer Gene Panels
XING Cancer Care specializes in genetic testing for a range of cancer types. We offer comprehensive genomic testing that pinpoints mutations that may be targeted with specific treatment options. Our aim is to provide a personalized report detailing the genetic characteristics of the tumour based on the detection of variants or mutations found in these genes.
Please refer to the available gene panels below.
Homologous Recombination Deficiency (HRD)
The HRD panel is a multi-gene test that analyses the entire coding regions of 27 key genes involved in homologous recombination repair deficiency. This panel is aimed at breast, ovarian, prostate, and pancreatic cancers.
Solid Tumour Panel (STP)
The STP panel is a multi-gene test that analyses hotspot alterations considered to be driving mutations in solid tumours; includes hotspots in 47 genes involved in colorectal, melanoma, NSCLC, pancreatic, GIST, and glioma.
The XGP72 panel is a multi-gene test for cancer predisposition and targeted treatment. The test analyses coding regions of 72 of the most clinically relevant genes that are commonly associated with cancer or with an increased risk for cancer.